Bambusa Therapeutics, Inc. Common stock

BBTX · Healthcare · Bambusa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops long-acting bispecific antibodies for the treatment of imm…

Bambusa Therapeutics, Inc. Common stock (BBTX), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 3 purchases and 0 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Nov 2 and filed Nov 3. The most active filer was Helmut Wolfgang Jeggle with 1 filing. Data as of Nov 7 2026.

Add to watchlist

Filings, ttm

3 buys · 0 sells

Traders, ttm

3 insiders

Volume, ttmiDollar value disclosed in the window

$58.6M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Nov 2

Filed Nov 3

ADViAverage daily dollar volume

$35.2M

market data

Share price · 12M

$15.73 (+4.9%)

Adjusted for splits and dividends.

Volume by month

Buys $58.6M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months

Helmut Wolfgang Jeggle Director 1 filing · 1 buy, 0 sales RP Ra Capital Management, L.P. Director 1 filing · 1 buy, 0 sales IS

Investment GmbH Salvia 10% owner 1 filing · 1 buy, 0 sales

Recent filings

Ra Capital Management, L.P.PURCHASE Director $46.6M
2,953,820 sh across 4 lots
Exec Oct 30
Filed Nov 3 · 6:09 PM ET Investment GmbH SalviaPURCHASE 10% owner $6.0M
375,000 sh × $16.00
Exec Nov 2
Filed Nov 2 · 4:07 PM ET Helmut Wolfgang JegglePURCHASE Director $6.0M
375,000 sh × $16.00
Exec Nov 2
Filed Nov 2 · 4:06 PM ET